Authors: Sara A. Hurvitz, Seock-Ah Im, Yen-Shen Lu, et. al. Abstract: LBA1008 Clinical Trial Registry Number: NCT02278120 Citation: J Clin Oncol 37, 2019 (suppl; abstr 1008) Background: The phase III MONALEESA-7 study (NCT02278120) is the first dedicated trial of endocrine therapy (ET) ± a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor in premenopausal...
Pro zobrazení tohoto obsahu je třeba být přihlášen.